Vir Biotechnology, Inc. (Nasdaq: VIR), today announced the appointment of Suzanne Topalian, M.D., to its Board of Directors, ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

From advances in agricultural science and sustainable bioenergy to medical breakthroughs to new automated technologies, ...

Vir Biotechnology (VIR) has signed a collaboration and license agreement with Gilead focused on three PRO-XTEN dual-masked ...

In this column, the author discusses how food biotechnology is evolving from scientific innovation into a scalable ...

Nautilus Biotechnology (NASDAQ:NAUT) reported third-quarter revenue of $200,000 as it continued its transition toward ...

Subcutaneous administration is designed to widen the therapeutic window and extend FL115’s potential across a broad range of ...

Biotechnology is a curious marriage of two seemingly disparate worlds. On one end, we have living organisms—wild, unpredictable celestial creations that can probably never be understood or appreciated ...

Nautilus Biotechnology, Inc. reported its financial results for the third quarter ended September 30, 2026. Revenue was $0.2 million for the third quarter of 2026, primarily driven by grant revenue ...

In recent years, China has accelerated its expansion in Latin America’s biotechnology sector, investing in production ...

The Treasury Department’s proposed restrictions on U.S. investment in Chinese biopharma collide with Beijing’s new export ...

Stem cell biotechnology is a field of biotechnology that develops tools and therapeutics through modification and engineering of stem cells. Stem cell biotechnology is important in regenerative ...